Insider Stock Trading History of Sarena Francis Willard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sarena Francis Willard since year 2005. The trader's CIK number is 1423786. At the time of this reporting, Sarena Francis Willard is the Chief Strategy Officer of Five Prime Therapeutics Inc . (stock ticker symbol FPRX). See this page for all insider trading activities at Five Prime Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Sarena Francis Willard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-18 FPRX Five Prime Therapeutics Inc Option Ex 3,636 5.54 20,143
2017-01-18 FPRX Five Prime Therapeutics Inc Sale 3,636 47.39 172,310
2016-11-28 FPRX Five Prime Therapeutics Inc Sale 1,710 60.14 102,839
2016-11-28 FPRX Five Prime Therapeutics Inc Option Ex 1,710 5.54 9,473
2016-11-23 FPRX Five Prime Therapeutics Inc Option Ex 13,465 6.89 92,773
2016-11-23 FPRX Five Prime Therapeutics Inc Sale 13,465 60.23 810,996
2016-11-25 FPRX Five Prime Therapeutics Inc Option Ex 21,189 6.21 131,689
2016-11-25 FPRX Five Prime Therapeutics Inc Sale 21,189 60.48 1,281,510
2016-03-29 FPRX Five Prime Therapeutics Inc Option Ex 4,450 8.49 37,780
2016-03-30 FPRX Five Prime Therapeutics Inc Option Ex 5,550 8.49 47,119
2016-03-29 FPRX Five Prime Therapeutics Inc Sale 4,450 40.00 178,000
2016-03-30 FPRX Five Prime Therapeutics Inc Sale 5,550 40.01 222,055
2016-01-27 FPRX Five Prime Therapeutics Inc Option Ex 30,000 8.64 259,200
2016-01-27 FPRX Five Prime Therapeutics Inc Sale 30,000 35.30 1,059,150

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sarena Francis Willard (Chief Strategy Officer of Five Prime Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.